Androgen deprivation therapy (ADT) induces the accumulation of TAMs around blood vessels and increases the expression of markers of a protumor phenotype, including folate receptor-beta (FR-β), MRC1 (CD206), CD169 and VISTA, in PvTAMs in human and mouse prostate cancers [174]. This evidence concerns the gene MRC1 and prostate carcinoma.